LibiGel
Phase 3- Indications
- Female sexual dysfunction, Hypoactive sexual desire disorder
Company intelligence / Profile preview
BioSante Pharmaceuticals
Lincolnshire, Illinois, United Statessec.gov ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
BioSante developed hormone therapy products including Elestrin™ (FDA-approved estradiol gel for menopause symptoms), LibiGel® (testosterone gel for female sexual dysfunction, reached Phase 3), and a pipeline of nanoparticle-based vaccine adjuvants. Elestrin™ was approved by the FDA in 2006. LibiGel® completed multiple clinical trials but did not reach commercialization before the company merged with ANI Pharmaceuticals in 2013. The CAP platform entered early clinical testing as a vaccine adjuvant.
- Therapeutic areas
- Women's HealthMen's Health
- Modalities
- Hormone therapies (transdermal gels for estradiol and testosterone)Monoclonal antibodiesNanoparticle-based vaccine adjuvants (calcium phosphate nanotechnology)
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
Bradley Pharmaceuticals/Kenwood Therapeutics Division – U.S. marketing partner for Elestrin™[6]Antares Pharma – licensed transdermal gel formulation technology[6]Corixa Corporation – non-exclusive licensee of Bio-VantÔ technology for vaccines[10]Wake Forest University & Cedars-Sinai Medical Center – licensors of triple hormone therapy patents[10]
Beyond the preview
Go deeper on BioSante Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BioSante Pharmaceuticals.